|
LARGE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53729999957864E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.44989999690304E-08 |
| Normal-vs-Stage2 |
2.907800E-02 |
| Normal-vs-Stage3 |
1.706160E-01 |
| Normal-vs-Stage4 |
7.298300E-03 |
| Stage1-vs-Stage2 |
5.101400E-01 |
| Stage1-vs-Stage3 |
2.830800E-01 |
| Stage1-vs-Stage4 |
2.080200E-01 |
| Stage2-vs-Stage3 |
6.864800E-01 |
| Stage2-vs-Stage4 |
2.569000E-01 |
| Stage3-vs-Stage4 |
2.330800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.16410000037004E-07 |
| Normal-vs-AfricanAmerican |
1.63099999999083E-05 |
| Normal-vs-Asian |
1.909690E-02 |
| Caucasian-vs-AfricanAmerican |
9.257000E-01 |
| Caucasian-vs-Asian |
9.508200E-01 |
| AfricanAmerican-vs-Asian |
9.136600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.98840005466639E-09 |
| Normal-vs-Female |
3.704000E-01 |
| Male-vs-Female |
9.6941000000017E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.184200E-03 |
| Normal-vs-Extreme_Weight |
2.36950004062209E-09 |
| Normal-vs-Obese |
1.398060E-02 |
| Normal-vs-Extreme_Obese |
3.53189999999781E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.734200E-02 |
| Normal_Weight-vs-Obese |
6.081200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.502800E-01 |
| Extreme_Weight-vs-Obese |
7.059000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.860600E-01 |
| Obese-vs-Extreme_Obese |
4.391900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.772400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.52230000003162E-07 |
| Normal-vs-Age(61-80Yrs) |
1.69400000027409E-07 |
| Normal-vs-Age(81-100Yrs) |
5.629100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.644830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.434560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.391250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.260200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.678800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.091600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.77480000485409E-08 |
| Normal-VS-Type2 PRCC |
4.99160000000387E-07 |
| Normal-VS-KIRP CIMP |
2.400400E-01 |
| Normal-VS-Unclassified PRCC |
1.219300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.914400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.578100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.025200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.731800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.879600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.617700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.85299999472855E-08 |
| Normal-vs-N1 |
5.967600E-01 |
| Normal-vs-N2 |
5.131200E-01 |
| N0-vs-N1 |
1.024640E-01 |
| N0-vs-N2 |
2.897800E-03 |
| N1-vs-N2 |
4.743200E-01 |
|
|
